Submission of Earning Call Transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09th November, 2026 The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Plot No. C/1, Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (East), Mumbai – 400 051. Scrip Code : 530999 Symbol : BALAMINES Dear Sir/Madam, Sub.: Submission of Earnings Call Transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Transcript of Q2FY27 Earnings Conference Call held on Wednesday, 4th November 2026. The transcript of the said Earnings Call is also available on the website of the Company at https://www.balajiamines.com/investor-relations.php. This is for your kind information and records. Thanking you. Yours faithfully, For Balaji Amines Limited Abhijeet Kothadiya Company Secretary & Compliance Officer Encl.: a/a “Balaji Amines Limited Quarter 2 Financial Year 2027 Earnings Conference Call” November 04, 2026 MANAGEMENT: MR. D. RAM REDDY – MANAGING DIRECTOR – BALAJI AMINES LIMITED MODERATOR: MR. AKSHAT VIJAY – ELARA SECURITIES PRIVATE LIMITED Page 1 of 12 Balaji Amines Limited November 04, 2026 Moderator: Ladies and gentlemen, good day, and welcome to the Balaji Amines Limited Quarter 2 Financial Year 2027 Earnings Conference Call hosted by Elara Securities Private Limited. As a reminder, all participant lines will be in listen-only mode. And there will be an opportunity for you to ask questions, after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touchtone phone. I now hand the conference over to Mr. Akshat Vijay from Elara Securities Private Limited. Thank you, and over to you, sir. Akshat Vijay: Ladies and gentlemen, good day, and welcome to the 2Q FY27 Conference Call of Balaji Amines hosted by Elara Securities Private Limited. I now hand over the conference to Mr. Ram Reddy from Balaji Amines. Thank you, and over to you, sir. D Ram Reddy: Thank you, Akshat. Good evening, everyone, and a warm welcome to Balaji Amines Limited Earnings Conference Call for the second quarter and half year ended September 30, 2026. I hope all of you have had an opportunity to go through our financial results, press release and investor presentation, which have been uploaded on the stock exchange and on our company website. Let me begin by putting the first half performance into perspective. H1 FY27 has been a strong period for Balaji Amines from a profitability standpoint. While the overall operating environment and sales volumes remained somewhat challenging, we have delivered meaningful improvement in revenue, EBITDA and profitability. This reflects our continued focus on product mix, operating efficiencies, cost management and strengthening the contribution from our diversified business portfolio. More importantly, we have continued to advance our expansion program with the commencement of commercial production at our expanded Acetonitrile facility and the commissioning of our DME plant. These developments mark an important transition in our growth journey as our focus increasingly shifts towards commercialization and utilization of the capacities created. The financial performance. Coming to our consolidated financial performance for Q2 FY27, revenue stood at INR472 crores compared to INR348 crores in Q2 FY26, registering year-on- year growth of approximately 36%. Consolidated EBITDA for the quarter stood at INR106 crores compared to INR67 crores in the corresponding quarter last year, reflecting a growth of approximately 58% EBITDA margin stood at 22% compared to 19% in Q2 FY26. Profit after tax for the quarter stood at INR67 crores against INR37 crores in Q2 FY26, registering a growth of approximately 82%. Diluted EPS for the quarter stood at INR20.76 per equity share compared to INR10.67 in the corresponding period last year. On a sequential basis, revenue improved to INR472 crores from INR461 crores in Q1 FY27. Page 2 of 12 Balaji Amines Limited November 04, 2026 Sales volumes also increased to 24,491 metric tons from 21,587 metric tons in the preceding quarter, indicating an improvement in overall offtake. However, EBITDA moderated to INR106 crores from INR121 crores in Q1 FY27 with margins moving from 26% to 22%. While profitability moderated sequentially, the year-on-year performance continues to reflect a significant improvement in our earnings profile. Looking at the first half of the FY26-27 performance, consolidated revenue for H1 FY27 stood at INR933 crores compared to INR715 crores in H1 FY26, registering a growth of approximately 31%. Consolidated EBITDA increased to INR227 crores from INR131 crores, representing a growth of approximately 74%. EBITDA margins improved to 24% from 18% in the corresponding period last year. Consolidated PAT for H1 FY27 stood at INR146 crores compared to INR74 crores in H1 FY26, registering a growth of approximately 98%. What is particularly encouraging is the improvement in profitability despite lower aggregate sales volumes. This demonstrates our ability to maintain earnings resilience through product portfolio management, operational efficiencies, and a continued focus on value addition. On a standalone basis, revenue for Q2 FY27 stood at INR434 crores, EBITDA at INR103 crores and PAT at INR69 crores. Balaji Amines Limited continues to maintain a zero debt position at the stand- alone level. Moving to our operational performance. Consolidated sales volumes for Q2 FY27 stood at 24,491 metric tons compared to 26,165 metric tons in Q2 FY26, representing a moderation of approximately 6%. However, on a sequential basis, volumes improved by approximately 13.5% compared to Q1 FY27. This improvement is encouraging and reflects better offtake during the quarter. Segment-wise, Q2 volumes comprised 6,525 metric tons from Amines, 8,974 metric tons from Amines Derivatives and 8,992 metric tons from Specialty Chemicals. For H1 FY27, consolidated sales volume stood at 46,078 metric tons compared to 53,735 metric tons in the corresponding period last year. Our diversified presence across Amines, derivatives and specialty chemicals continues to provide stability to the business. We cater to several end-user industries, including pharmaceuticals, agrochemicals, paints, resins, solvents, rubber chemicals and other industrial applications. Going forward, improving volumes alongside maintaining the improved profitability profile will remain an important priority. Let me now share some of the important developments across our manufacturing facilities. During the quarter, we achieved a significant milestone with the commencement of commercial production at our process improved Acetonitrile plant. With this improved process and the expanded capacity has increased to 1,440 tons per month. The upgraded facility incorporates improved technology and enhanced process efficiencies. This Page 3 of 12 Balaji Amines Limited November 04, 2026 expansion strengthens our ability to cater to customer requirements and increases our strength in the Acetonitrile market. Our focus will now be on stabilizing operations, developing the customer base and progressively improving utilization of this expanded capacity. It is with great pleasure to share the news of Dimethyl Ether Road Tanker valves approval from the PESO Nagpur office after a thorough testing process. We are actively working towards developing the customer ecosystem and exploring opportunities in both domestic and international markets. The Aerosol segment represents an important opportunity for DME and our efforts are directed towards establishing a sustainable customer and distribution network. We believe DME can become an important addition to our product portfolio as [Showing first 8,000 characters — download PDF for full document]